GCM
DCPH

Graham Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Graham Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,448
Closed -$218K – 1349
2023
Q2 		$218K Buy
+15,448
New +$221K 0.01% 789
2022
Q4 		– Sell
-45,509
Closed -$841K – 1424
2022
Q3 		$841K Buy
+45,509
New +$714K 0.03% 559
2022
Q1 		– Sell
-58,508
Closed -$571K – 1053
2021
Q4 		$571K Buy
+58,508
New +$1.1M 0.02% 149

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Graham Capital Management's DCPH Position: Q3 2023 in Review

Graham Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2023, closing a stake of 15,448 shares — an estimated $218K sold.

Graham Capital Management first reported a position in DCPH in Q4 2021 and held it in 3 quarters. The position peaked at $841K in Q3 2022. 157 funds tracked by Wall St. Rank hold DCPH as of Q3 2023.

  • Graham Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Graham Capital Management sold 15,448 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $218K.
  • Graham Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Graham Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $841K in Q3 2022.
  • 157 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Graham Capital Management's 13F filing for Q3 2023, filed 22 Nov 2023.